JHJiejie Hu

Jiejie Hu

*This is an algorithmically generated author record based on publicly available information.

Jiejie Hu has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Yang Yu

    Department of Breast Surgery, Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China

    3 shared publications
  • Chenlu Liang

    Chinese Acad Sci, Hangzhou Inst Med HIM, Zhejiang Canc Hosp, Breast Canc Dept, Hangzhou 310022, Zhejiang, Peoples R China

    2 shared publications
  • Meizhen Zhu

    Chinese Acad Sci, Hangzhou Inst Med HIM, Zhejiang Canc Hosp, Breast Canc Dept, Hangzhou 310022, Zhejiang, Peoples R China

    2 shared publications
  • Xianghou Xia

    Chinese Acad Sci, Hangzhou Inst Med HIM, Zhejiang Canc Hosp, Breast Canc Dept, Hangzhou 310022, Zhejiang, Peoples R China

    2 shared publications
  • Chengdong Qin

    Chinese Acad Sci, Hangzhou Inst Med HIM, Zhejiang Canc Hosp, Breast Canc Dept, Hangzhou 310022, Zhejiang, Peoples R China

    1 shared publication
  • Dehong Zou

    Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou, China

    1 shared publication

Latest Publications

  • Open Access

    Oncoplastic Breast-Conserving Surgery for Upper Inner Quadrant Breast Cancer Using Pedicled Pectoralis Major Myofascial Flap

    by Jie Jie Hu, Chengdong Qin, Siyuan Liu, Meizhen Zhu, Xianghou Xia, Chenlu Liang, Jiefei Mao, Fanrong Zhang, Yang Yu

    Background: Oncoplastic breast-conserving surgery (OBCS) has emerged as a pivotal approach in the management of breast cancer, ensuring both oncological safety and aesthetic outcomes. However, challenges persist, particularly in upper inner quadrant (UIQ) tumors, where achieving satisfactory cosmetic results while preserving oncological integrity remains intricate. Methods: 15 patients with UIQ breast cancer received OBCS using a pedicled pectoralis major myofascial flap (PMMF). All medical records, preoperative imaging findings, and post-operative data were gathered retrospectively. Results: This study showed good cosmetic outcomes after OBCS of the upper inner pole and the patients were satisfied with the results. There were no recurrences or metastases in any of the patients. Conclusion: PMMF as a technique is reliable blood supply, easy to master, no need for additional incision, and minimal surgical trauma and functional impact.


  • Open Access

    The Guiding Significance of the Number of Positive Sentinel Lymph Nodes in Frozen Section for Intraoperative Axillary Dissection in Early Breast Cancer

    by Chenlu Liang, Liuyi Li, Meizhen Zhu, Jiejie Hu, Yang Yu

    Purpose: The results of large randomised trials have changed the treatment strategy of axillary lymph nodes. Axillary lymph node dissection (ALND) can be avoided in some patients with one to two sentinel lymph nodes (SLNs) metastasis based on final paraffin section (FPS) results which called into question the need for intraoperative frozen section (FS). This study aims to assess the guiding value of the number of positive SLN detected via FS for intraoperative ALND. Patients and Methods: This study retrospectively analyzed data from 3303 patients with breast cancer who underwent SLN biopsy between 2015 and 2019. Combined with the FPS results, FS sensitivity, specificity, and false negative rate (FNR) were calculated and the difference in the number of positive SLNs between FS and FPS was analyzed. Results: The overall FNR of FS was 23.21%, which was 76.47% in isolated tumor cells, 62.28% in micrometastasis, and 12.09% in macrometastatic disease. The size of SLN metastasis were significantly associated with a higher FNR (p< 0.001). The accuracy rate of the number of positive SLNs detected via FS was 92.62%. Human epidermal growth factor receptor 2 (HER2) (p< 0.03) and Ki67 (p< 0.02) were significant factors affecting the accuracy rate. Conclusion: FS is a effective method for SLN biopsy, ALND can be avoided in patients with one or two positive SLNs detected via FS.


  • Open Access

    Dissection of Level III Axillary Lymph Nodes in Breast Cancer

    by Jiejie Hu, Xianghou Xia, Hongjian Yang, Yang Yu

    Axillary lymph node dissection is an indispensable step in modified radical mastectomy for breast cancer. It is the most reliable method and the golden standard to determine the status of axillary lymph nodes. It is also of great importance to evaluate the prognosis and develop treatment plans for breast cancer patients. Axillary lymph node dissection can be anatomically divided into levels I, II, and III. Level I and Level II axillary lymph dissection is the standard clinical treatment of axillary lymph nodes positive breast cancer, whereas level III axillary lymph node dissection has been controversial. Level III axillary lymph node metastasis is one of the important factors that can easily cause distant metastasis and recurrence. It is also an important index to estimate the prognosis of breast cancer patients. To facilitate the decision of whether or not to perform level III lymph node dissection, we reviewed the indications, complications, and surgical procedures of level III lymph node dissection.


  • Open Access

    Breast carcinoma associated with prolactinoma: A case report

    by Yurong Zheng, Wenju Mo, Yang Yu, Dehong Zou, Xiangming He, Xianghou Xia, Jiejie Hu

    We report a 28-year-old woman who presented with a 6-year history of milk-like discharge from both of her nipples and was diagnosed with prolactinoma based on computed tomography (CT) findings and serum prolactin level. Further breast examination revealed a mass located in the upper outer region of the left breast. She underwent subtotal pituitary tumor resection. Thereafter, modified radical mastectomy was performed for left breast cancer. Twelve years after treatment, prolactinoma recurrence was detected, and bromocriptine therapy was administered. No recurrence of breast cancer was discovered. Based on this case report, we stress the importance of prolactin levels due to their possible biologic effects on breast cancer induction or growth.